Pentagrit Discovery - Zebrafish CRO
Slogan: "We are a Pre-Clinical Development CRO with 100% focus on Zebrafish as a research model for screening service."
Description: Pentagrit Discovery is a Pre-Clinical Development CRO specializing in Zebrafish as a research model for screening services. The company boasts expertise in monitoring hundreds of compounds in various zebrafish models that replicate human pathophysiology. Led by a team of patriarchs from global leading academia, the company's focus on the robust zebrafish as a research model sets them apart. Pentagrit employs three main methods of model development - Genetic models validated through phenotype, genotype screens, and inbreeding, Xenografts of various tumor cell lines, and Inflammatory exposure to pathogens or antigens.
Pentagrit Discovery also offers the Z-ePhys - Neuro-Behavioral Toxicity Screening System, enabling the identification of promising candidates early in the discovery pipeline and accurate measure of dose range responses and neurobehavior toxicity under varying stimuli environments. The compound data generated from Z-ephys can be decoded to establish roles of functional groups.
Founded: 2011
Headquarter: India
Last Investment: Not available
The company's niche focus on Zebrafish as a research model, combined with its experienced leadership, sets Pentagrit Discovery apart in the pre-clinical development space. Their innovative Z-ePhys system and dedication to accurate research models make them a compelling venture for investment in the pre-clinical research industry.
There is no investment information
No recent news or press coverage available for Pentagrit Discovery - Zebrafish CRO.